F. Durães, M. Pinto, and E. Sousa, Old Drugs as New Treatments for Neurodegenerative Diseases, Pharmaceuticals, vol.11, 2018.

C. Carvalho and P. I. Moreira, Oxidative stress: A major player in cerebrovascular alterations associated to neurodegenerative events, Front. Physiol, vol.9, 2018.

S. Franco-iborra, M. Vila, and C. Perier, Mitochondrial quality control in neurodegenerative diseases: Focus on Parkinson's disease and Huntington's disease, Front. Neurosci, vol.12, 2018.

H. A. Elfawy and B. Das, Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: Etiologies and therapeutic strategies, Life Sci, vol.218, pp.165-184, 2019.

J. Cummings, G. Lee, A. Ritter, and K. Zhong, Alzheimer's disease drug development pipeline, Alzheimers Dement. (N. Y, vol.4, pp.195-214, 2018.

A. W. Yeung, N. T. Tzvetkov, and A. G. Atanasov, When Neuroscience Meets Pharmacology: A Neuropharmacology Literature Analysis, Front. Neurosci, vol.12, 2018.

M. D. Pandareesh, R. B. Mythri, and M. M. Srinivas-bharath, Bioavailability of dietary polyphenols: Factors contributing to their clinical application in CNS diseases, Neurochem. Int, vol.89, pp.198-208, 2015.

M. Kujawska and J. Jodynis-liebert, Polyphenols in Parkinson's disease: A systematic review of in vivo studies, Nutrients, vol.10, 2018.

A. Namsi, T. Nury, H. Hamdouni, A. Yammine, A. Vejux et al., Induction of neuronal differentiation of murine N2a cells by two polyphenols present in the Mediterranean diet mimicking neurotrophins activities: Resveratrol and apigenin, vol.6, 2018.

M. Akagi, N. Matsui, H. Akae, N. Hirashima, N. Fukuishi et al., Nonpeptide neurotrophic agents useful in the treatment of neurodegenerative diseases such as Alzheimer's disease, J. Pharmacol. Sci, vol.127, pp.155-163, 2015.

F. Moosavi, R. Hosseini, L. Saso, and O. Firuzi, Modulation of neurotrophic signaling pathways by polyphenols. Drug Des, Dev. Ther, vol.10, pp.23-42, 2015.

K. E. Murphy and J. J. Park, Can Co-activation of Nrf2 and neurotrophic signaling pathway slow Alzheimer's disease?, Int. J. Mol. Sci, vol.18, 1168.

T. B. Sampaio, A. S. Savall, M. E. Gutierrez, and S. Pinton, Neurotrophic factors in Alzheimer's and Parkinson's diseases: Implications for pathogenesis and therapy, Neural Regen. Res, vol.12, pp.549-557, 2017.

M. C. Tonon, L. Désy, P. Nicolas, H. Vaudry, and G. Pelletier, Immunocytochemical localization of the endogenous benzodiazepine ligand octadecaneuropeptide (ODN) in the rat brain, Neuropeptides, vol.15, pp.17-24, 1990.

J. Alfonso, C. Le-magueresse, A. Zuccotti, K. Khodosevich, and H. Monyer, Diazepam binding inhibitor promotes progenitor proliferation in the postnatal SVZ by reducing GABA signaling, Cell Stem Cell, vol.10, pp.76-87, 2012.

P. Lacor, J. Benavides, and B. Ferzaz, Enhanced expression of the peripheral benzodiazepine receptor (PBR) and its endogenous ligand octadecaneuropeptide (ODN) in the regenerating adult rat sciatic nerve, Neurosci. Lett, vol.220, pp.61-65, 1996.

Y. Hamdi, H. Kaddour, D. Vaudry, J. Leprince, A. Zarrouk et al., Octadecaneuropeptide ODN prevents hydrogen, peroxide-induced oxidative damage of biomolecules in cultured rat astrocytes, Peptides, vol.71, pp.56-65, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01267516

I. Ghouili, S. Bahdoudi, F. Morin, F. Amri, Y. Hamdi et al., Endogenous expression of ODN-related peptides in astrocytes contributes to cell protection against oxidative stress: Astrocyte-neuron crosstalk relevance for neuronal survival, Mol. Neurobiol, vol.55, pp.4596-4611, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01928325

H. Kaddour, Y. Hamdi, D. Vaudry, M. Basille, L. Desrues et al., The octadecaneuropeptide ODN prevents 6-hydroxydopamine-induced apoptosis of cerebellar granule neurons through a PKC-MAPK-dependent pathway, J. Neurochem, vol.125, pp.620-633, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01962763

H. Kaddour, Y. Hamdi, F. Amri, S. Bahdoudi, I. Bouannee et al., Antioxidant and anti-apoptotic activity of octadecaneuropeptide against 6-OHDA toxicity in cultured at astrocytes, J. Mol. Neurosci, vol.69, pp.1-16, 2018.

S. Bahdoudi, I. Ghouili, M. Hmiden, J. L. Do-rego, B. Lefranc et al., Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson's disease, Cell. Mol. Life Sci, vol.75, pp.2075-2091, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01939287

O. Masmoudi-kouki, Y. Hamdi, I. Ghouili, S. Bahdoudi, H. Kaddour et al., ODN. Curr. Pharm. Des, vol.24, pp.3918-3925, 2018.

Y. Hamdi, H. Kaddour, D. Vaudry, S. Bahdoudi, S. Douiri et al., The octadecaneuropeptide ODN protects astrocytes against hydrogen peroxide-induced apoptosis via a PKA/MAPK-dependent mechanism, PLoS ONE, vol.7, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01962756

M. Depreter, M. Espeel, and F. Roels, Human peroxisomal disorders, Microsc. Res. Tech, vol.61, pp.203-223, 2003.

C. Lismont, M. Nordgren, P. P. Van-veldhoven, and M. Fransen, Redox interplay between mitochondria and peroxisomes. Front, Cell Dev. Biol, vol.3, p.35, 2015.

B. Wang, P. P. Van-veldhoven, C. Brees, N. Rubio, M. Nordgren et al., Mitochondria are targets for peroxisome-derived oxidative stress in cultured mammalian cells, Free Radic Biol Med, vol.65, pp.882-894, 2013.

M. Fransen, C. Lismont, and P. Walton, The Peroxisome-mitochondria connection: How and why?, Int. J. Mol. Sci, vol.18, 1126.

J. Berger, F. Dorninger, S. Forss-petter, and M. Kunze, Peroxisomes in brain development and function, Biochim. Biophys. Acta, vol.1863, pp.934-955, 2016.

A. Lee, Y. Hirabayashi, S. K. Kwon, T. L. Lewis, . Jr et al., Emerging roles of mitochondria in synaptic transmission and neurodegeneration, Curr. Opin. Physiol, vol.3, pp.82-93, 2018.

E. Baumgart, I. Vanhorebeek, M. Grabenbauer, M. Borgers, P. E. Declercq et al., Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse), Am. J. Pathol, vol.159, pp.1477-1494, 2001.

R. Dirkx, I. Vanhorebeek, K. Martens, A. Schad, M. Grabenbauer et al., Absence of peroxisomes in mouse hepatocytes causes mitochondrial and ER abnormalities, Hepatology, vol.41, pp.868-878, 2005.

A. Peeters, P. Fraisl, . Van-den, S. Berg, E. Ver-loren-van-themaat et al., Carbohydrate metabolism is perturbed in peroxisome-deficient hepatocytes due to mitochondrial dysfunction, AMP-activated protein kinase (AMPK) activation, and peroxisome proliferator-activated receptor ? coactivator 1? (PGC-1?) suppression, J. Biol. Chem, vol.286, pp.42162-42179, 2011.

A. Peeters, A. B. Shinde, R. Dirkx, J. Smet, K. De-bock et al., Mitochondria in peroxisome-deficient hepatocytes exhibit impaired respiration, depleted DNA, and PGC-1? independent proliferation, Biochim. Biophys. Acta, vol.1853, pp.285-298, 2015.

J. López-erauskin, J. Galino, M. Ruiz, J. M. Cuezva, I. Fabregat et al., Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy, Hum. Mol. Genet, vol.22, pp.3296-3305, 2013.

P. Wang, Q. Wang, Y. Yin, Z. Yang, W. Li et al., Association between peroxisome proliferator-activated receptor gamma gene polymorphisms and atherosclerotic diseases: A meta-analysis of case-control studies, J. Atheroscler. Thromb, vol.22, pp.912-925, 2015.

F. A. Cabezas-opazo, K. Vergara-pulgar, M. J. Pérez, C. Jara, C. Osorio-fuentealba et al., Mitochondrial dysfunction contributes to the pathogenesis of Alzheimer's disease, Oxid. Med. Cell. Longev, vol.509654, 2015.

M. Rodriguez, C. Rodriguez-sabate, I. Morales, A. Sanchez, and M. Sabate, Parkinson's disease as a result of aging, Aging Cell, vol.14, pp.293-308, 2015.

R. Ruffoli, A. Bartalucci, A. Frati, and F. Fornai, Ultrastructural studies of ALS mitochondria connect altered function and permeability with defects of mitophagy and mitochondriogenesis, Front. Cell. Neurosci, vol.9, p.341, 2015.

M. Mamelak, Energy and the Alzheimer brain, Neurosci. Biobehav. Rev, vol.75, pp.297-313, 2017.

G. Campbell and D. J. Mahad, Mitochondrial dysfunction and axon degeneration in progressive multiple sclerosis, FEBS Lett, vol.592, pp.1113-1121, 2018.

G. Lizard, O. Rouaud, J. Demarquoy, M. Cherkaoui-malki, and L. Iuliano, Potential roles of peroxisomes in Alzheimer's disease and in dementia of the Alzheimer's type, J. Alzheimers Dis, vol.29, pp.241-254, 2012.

E. Gray, C. Rice, K. Hares, J. Redondo, K. Kemp et al., Reductions in neuronal peroxisomes in multiple sclerosis grey matter, Mult. Scler, vol.20, pp.651-659, 2014.

E. Gray, K. Kemp, K. Hares, J. Redondo, C. Rice et al., Increased microglial catalase activity in multiple sclerosis grey matter, Brain Res, vol.1559, pp.55-64, 2014.

V. K. Senanayake, W. Jin, A. Mochizuki, B. Chitou, and D. B. Goodenowe, Metabolic dysfunctions in multiple sclerosis: Implications as to causation, early detection, and treatment, a case control study, BMC Neurol, vol.15, 2015.

A. Zarrouk, J. M. Riedinger, S. H. Ahmed, S. Hammami, W. Chaabane et al., Fatty acid profiles in demented patients: Identification of hexacosanoic acid (C26:0) as a blood lipid biomarker of dementia, J. Alzheimers Dis, vol.44, pp.1349-1359, 2015.

A. Zarrouk, M. Debbabi, M. Bezine, E. M. Karym, A. Badreddine et al., Lipid Biomarkers in Alzheimer's Disease. Curr. Alzheimer Res, vol.15, pp.303-312, 2018.

M. Islinger, A. Voelkl, H. D. Fahimi, and M. Schrader, The peroxisome: An update on mysteries 2.0. Histochem, Cell Biol, vol.150, pp.443-471, 2018.

M. Schrader, J. Costello, L. F. Godinho, and M. Islinger, Peroxisome-mitochondria interplay and disease, J. Inherit. Metab. Dis, vol.38, pp.681-702, 2015.

M. Agostini, F. Romeo, S. Inoue, M. V. Niklison-chirou, A. J. Elia et al., Metabolic reprogramming during neuronal differentiation, Cell Death Differ, vol.23, pp.1502-1514, 2016.

E. Costa and A. Guidotti, Diazepam binding inhibitor (DBI): A peptide with multiple biological actions, Life Sci, vol.49, pp.325-344, 1991.

D. Vaudry, A. Falluel-morel, S. Bourgault, M. Basille, D. Burel et al., Pituitary adenylate cyclase activating polypeptide and its receptors: 20 years after the discovery, Pharmacol. Rev, vol.61, pp.283-357, 2009.
URL : https://hal.archives-ouvertes.fr/hal-02058111

T. Hirabayashi, T. Nakamachi, and S. Shioda, Discovery of PACAP and its receptors in the brain, J. Headache Pain, vol.19, 2018.

D. Vaudry, Y. Chen, A. Ravni, C. Hamelink, A. G. Elkahloun et al., Analysis of the PC12 cell transcriptome after differentiation with pituitary adenylate cyclase-activating polypeptide

, J. Neurochem, vol.83, pp.1272-1284, 2002.

D. L. Manecka, S. F. Mahmood, L. Grumolato, I. Lihrmann, and Y. Anouar, Pituitary adenylate cyclase-activating polypeptide (PACAP) promotes both survival and neuritogenesis in PC12 cells through activation of nuclear factor ?B (NF-?B) pathway: Involvement of extracellular signal-regulated kinase (ERK), calcium, and c-REL, J. Biol. Chem, vol.288, pp.14936-14948, 2013.

M. V. Chao, R. Rajagopal, and F. S. Lee, Neurotrophin signalling in health and disease, Clin. Sci, vol.110, pp.167-173, 2006.

J. Leprince, H. Oulyadi, D. Vaudry, O. Masmoudi, P. Gandolfo et al., Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN. Design of a potent endozepine antagonist, Eur. J. Biochem, vol.268, pp.6045-6057, 2001.
URL : https://hal.archives-ouvertes.fr/hal-01972542

W. Kharroubi, S. H. Ahmed, T. Nury, P. Andreoletti, Z. Haouas et al., Evidence of hormesis on human neuronal SK-N-BE cells treated with sodium arsenate: Impact at the mitochondrial level, Environ. Sci. Pollut. Res. Int, vol.23, pp.8441-8452, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01463067

T. Nury, R. Sghaier, A. Zarrouk, F. Ménétrier, T. Uzun et al., Induction of peroxisomal changes in oligodendrocytes treated with 7-ketocholesterol: Attenuation by ?-tocopherol, Biochimie, vol.153, pp.181-202, 2018.

C. Schnell, Y. Hagos, and S. Hülsmann, Active sulforhodamine 101 uptake into hippocampal astrocytes, PLoS ONE, vol.7, 2012.

T. Moilanen and T. Nikkari, The effect of storage on the fatty acid composition of human serum, Clin. Chim. Acta, vol.114, pp.111-116, 1981.

W. R. Morrison and L. M. Smith, Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol, J. Lipid Res, vol.5, pp.600-608, 1964.

M. Debbabi, T. Nury, A. Zarrouk, N. Mekahli, M. Bezine et al., Protective effects of -tocopherol, -tocopherol and oleic acid, three compounds of olive oils, and no effect of trolox, on 7-ketocholesterol-induced mitochondrial and peroxisomal dysfunction in microglial BV-2 cells, Int. J. Mol. Sci, vol.17, 1973.
URL : https://hal.archives-ouvertes.fr/hal-01463786

A. Badreddine, A. Zarrouk, E. M. Karym, M. Debbabi, T. Nury et al., Argan Oil-Mediated Attenuation of Organelle Dysfunction, Oxidative Stress and Cell Death Induced by 7-Ketocholesterol in Murine Oligodendrocytes 158N, Int. J. Mol. Sci, vol.18, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01685177

M. A. Mitsche, J. G. Mcdonald, H. H. Hobbs, and J. Cohen, Flux analysis of cholesterol biosynthesis in vivo reveals multiple tissue and cell-type specific pathways, vol.4, p.7999, 2015.

V. Leoni, L. Strittmatter, G. Zorzi, F. Zibordi, S. Dusi et al., Metabolic consequences of mitochondrial coenzyme A deficiency in patients with PANK2 mutations, Mol. Genet. Metab, vol.105, pp.463-471, 2011.

V. Leoni, T. Nury, A. Vejux, A. Zarrouk, C. Caccia et al., Mitochondrial dysfunctions in 7-ketocholesterol-treated 158N oligodendrocytes without or with ?-tocopherol: Impacts on the cellular profil of tricarboxylic cycle-associated organic acids, long chain saturated and unsaturated fatty acids, oxysterols, cholesterol and cholesterol precursors, J. Steroid Biochem. Mol. Biol, vol.169, pp.96-110, 2017.

H. H. Engelhard, Flow cytometric applications of Sulforhodamine 101 as a fluorescent stain for total cellular protein, Biotech. Histochem, vol.72, pp.1-9, 1997.

J. L. Costello, J. B. Passmore, M. Islinger, and M. Schrader, Multi-localized Proteins: The Peroxisome-Mitochondria Connection, Subcell. Biochem, vol.89, pp.383-415, 2018.

M. Schrader and H. D. Fahimi, Growth and division of peroxisomes, Int. Rev. Cytol, vol.255, pp.237-290, 2006.

M. Schrader and H. D. Fahimi, The peroxisome: Still a mysterious organelle, Histochem Cell Biol, vol.129, pp.421-440, 2008.

D. Trompier, A. Vejux, A. Zarrouk, C. Gondcaille, F. Geillon et al., Brain peroxisomes, Biochimie, vol.98, pp.102-110, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01185043

R. J. Wanders and H. R. Waterham, Biochemistry of mammalian peroxisomes revisited, Annu Rev. Biochem, vol.75, pp.295-332, 2006.

W. M. Pandak, S. Ren, D. Marques, E. Hall, K. Redford et al., Transport of cholesterol into mitochondria is rate-limiting for bile acid synthesis via the alternative pathway in primary rat hepatocytes, J. Biol. Chem, vol.277, pp.48158-48164, 2002.

R. J. Wanders, Peroxisomes, lipid metabolism, and peroxisomal disorders, Mol. Genet. Metab, vol.83, pp.16-27, 2004.

R. J. Wanders, Metabolic functions of peroxisomes in health and disease, Biochimie, vol.98, pp.36-44, 2014.

M. Knobloch, The Role of Lipid Metabolism for Neural Stem Cell Regulation, vol.3, pp.61-71, 2017.

M. Katakura, M. Hashimoto, T. Okui, H. M. Shahdat, K. Matsuzaki et al., Omega-3 polyunsaturated Fatty acids enhance neuronal differentiation in cultured rat neural stem cells, Stem Cells Int, vol.490476, 2013.

V. Cartocci, M. Segatto, I. Di-tunno, S. Leone, F. W. Pfrieger et al., Modulation of the isoprenoid/cholesterol biosynthetic pathway during neuronal differentiation in vitro, J. Cell. Biochem, vol.117, pp.2036-2044, 2016.

M. Malagon, H. Vaudry, F. Van-strien, G. Pelletier, F. Gracia-navarro et al., Ontogeny of diazepam-binding inhibitor-related peptides (endozepines) in the rat brain, Neuroscience, vol.57, pp.777-786, 1993.

M. Ebadi, R. M. Bashir, M. L. Heidrick, F. M. Hamada, H. E. Refaey et al., Neurotrophins and their receptors in nerve injury and repair, Neurochem. Int, vol.30, pp.347-374, 1997.

B. Botia, M. Basille, A. Allais, E. Raoult, A. Falluel-morel et al., Neurotrophic effects of PACAP in the cerebellar cortex, Peptides, vol.28, pp.1746-1752, 2007.

O. Masmoudi-kouki, S. Douiri, Y. Hamdi, H. Kaddour, S. Bahdoudi et al., Pituitary adenylate cyclase-activating polypeptide protects astroglial cells against oxidative stress-induced apoptosis, J. Neurochem, vol.117, pp.403-411, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01973032

O. Blondel, C. Collin, W. J. Mccarran, S. Zhu, R. Zamostiano et al., A glia-derived signal regulating neuronal differentiation, J Neurosci, vol.20, pp.8012-8020, 2000.

S. Oz and Y. Ivashko-pachima, Gozes, I. The ADNP derived peptide, NAP modulates the tubulin pool: Implication for neurotrophic and neuroprotective activities, PLoS ONE, vol.7, 2012.

L. A. Greene and J. C. Mcguire, Induction of ornithine decarboxylase by nerve growth factor dissociated from effects on survival and neurite outgrowth, Nature, vol.276, pp.191-194, 1978.

K. T. Noh, K. H. Son, I. D. Jung, H. K. Kang, S. A. Hwang et al., Protein kinase C ? (PKC?)-extracellular signal-regulated kinase 1/2 (ERK1/2) signaling cascade regulates glycogen synthase kinase-3 (GSK-3) inhibition-mediated interleukin-10 (IL-10) expression in lipopolysaccharide (LPS)-induced endotoxemia, J. Biol. Chem, vol.287, pp.14226-14233, 2012.

Y. Li, Y. B. Dai, J. Y. Sun, Y. Xiang, J. Yang et al., Neuroglobin Attenuates Beta Amyloid-Induced Apoptosis Through Inhibiting Caspases Activity by Activating PI3K/Akt Signaling Pathway, J. Mol. Neurosci, vol.58, pp.28-38, 2016.

A. S. Algarni, A. J. Hargreaves, and J. M. Dickenson, Activation of transglutaminase 2 by nerve growth factor in differentiating neuroblastoma cells: A role in cell survival and neurite outgrowth, Eur. J. Pharmacol, vol.820, pp.113-129, 2018.

A. S. Almeida and H. L. Vieira, Role of Cell Metabolism and Mitochondrial Function During Adult Neurogenesis, Neurochem. Res, vol.42, pp.1787-1794, 2017.

G. R. Campbell, J. T. Worrall, and D. J. Mahad, The central role of mitochondria in axonal degeneration in multiple sclerosis, Mult. Scler. J, vol.20, pp.1806-1813, 2014.

F. Sedel, D. Bernard, D. M. Mock, and A. Tourbah, Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis, Neuropharmacology, vol.110, pp.644-653, 2016.

S. Savary, D. Trompier, P. Andréoletti, F. Le-borgne, J. Demarquoy et al., Fatty acids-Induced lipotoxicity and inflammation, Curr. Drug Metab, vol.13, pp.1358-1370, 2012.

M. Thiemann, M. Schrader, A. Völkl, E. Baumgart, and H. D. Fahimi, Interaction of peroxisomes with microtubules. In vitro studies using a novel peroxisome-microtubule binding assay, Eur. J. Biochem, vol.267, pp.6264-6275, 2000.

R. L. Farr, C. Lismont, S. R. Terlecky, and M. Fransen, Peroxisome biogenesis in mammalian cells: The impact of genes and environment, Biochim. Biophys. Acta, vol.1863, pp.1049-1060, 2016.

, This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution, Sample Availability: Samples of the compounds are available from the authors. © 2019 by the authors. Licensee MDPI